Stock Information

Stock Quote & Chart (TRDA)

Previous Close
Open
Volume
Exchange
Day High
Day Low
52-Week High
52-Week Low

Last Updated: 30 Dec, 2024 12:20 PM EST Minimum 15 minute delay

Minimum 15 minutes delayed. Source: LSEG

Analyst Coverage

Entrada Therapeutics is followed by the analysts named below

Company Name
Evercore ISI
 Umer Raffat and Jonathan Miller, PhD
Goldman Sachs
 Chris Shibutani, MD
H.C. Wainwright
 Raghuram Selvaraju, PhD
Oppenheimer
 Francois Brisebois
Roth Capital Partners
 Boobalan Pachaiyappan, PhD
TD Cowen
 Joseph Thome, PhD
William Blair
 Myles Minter, PhD

Entrada Therapeutics is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Entrada Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Entrada Therapeutics or its management. Entrada Therapeutics does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Quick access to common resources

Frequently Asked Questions Frequent questions about owning stock in Entrada. SEC Filings View current and past SEC filings in various easy-to-access file formats. Events & Presentation View our latest events and presentation.